Transcripts Celyad Oncology SA Börse Stuttgart

Actions

Temps Différé Börse Stuttgart Autres places de cotation 21:46:26 21/07/2026			Varia. 5j.	Varia. 1 janv.
0,2270 ^EUR	+7,58%		+2,43%	+33,97%

14/07	Celyad Oncology va lever des fonds via un placement privé	MT
15/04	Prelude Therapeutics Incorporated nomme Charles Morris au poste de Chief Medical Officer, avec effet au 20 avril 2026	CI

05/09/23	Transcript : Celyad Oncology SA, H1 2023 Earnings Call, Sep 05, 2023
24/03/23	Transcript : Celyad Oncology SA, 2022 Earnings Call, Mar 24, 2023
05/08/22	Transcript : Celyad Oncology SA, H1 2022 Earnings Call, Aug 05, 2022
25/03/22	Transcript : Celyad Oncology SA, 2021 Earnings Call, Mar 25, 2022
13/12/21	Transcript : Celyad Oncology SA - Special Call
05/08/21	Transcript : Celyad Oncology SA, H1 2021 Earnings Call, Aug 05, 2021
20/07/21	Transcript : Celyad Oncology SA - Special Call
11/06/21	Transcript : Celyad Oncology SA - Special Call
25/03/21	Transcript : Celyad Oncology SA, 2020 Earnings Call, Mar 25, 2021
09/03/21	Transcript : Celyad Oncology SA Presents at H.C. Wainwright Virtual Global Life Sciences Conference, Mar-09-2021 07:00 AM
07/12/20	Transcript : Celyad Oncology SA - Special Call
29/09/20	Transcript : Celyad Oncology SA - Special Call
07/08/20	Transcript : Celyad Oncology SA, H1 2020 Earnings Call, Aug 07, 2020
01/06/20	Transcript : Celyad SA - Special Call
25/03/20	Transcript : Celyad SA, 2019 Earnings Call, Mar 25, 2020